Impaired liver regeneration and increased oval cell numbers following T cell-mediated hepatitis

Hepatology

Volumn 46, Issue 1, 2007, Pages 229-241

  Hines, Ian N ^a,b   Kremer, Michael ^a   Isayama, Fuyumi ^a   Perry, Ashley W ^a   Milton, Richard J ^a   Black, April L ^a   Byrd, Christy L ^a   Wheeler, Michael D ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATAXIN 1; CYCLIN D; CYCLIN E; STAT3 PROTEIN; STEM CELL FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; LIVER INJURY; LIVER REGENERATION; LIVER TRANSPLANTATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE INJURY;

ANIMALS; CELL SURVIVAL; CONCANAVALIN A; GENES, REPORTER; HEPATITIS; INTERFERON TYPE II; INTERLEUKIN-6; KILLER CELLS, NATURAL; LIVER REGENERATION; MALE; MICE; MICE, INBRED C57BL; MICE, SCID; MICE, TRANSGENIC; POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34547435358     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21674     Document Type: Article

References (50)

1. White SA, Al Mukhtar A, Lodge JP, Pollard SG. Progress in living donor liver transplantation. Transplant Proc 2004;36:2720-2726.
2. Schemmer P, Mehrabi A, Friess H, Sauer P, Schmidt I, Buchler MW, et al. Living related liver transplantation: the ultimate technique to expand the donor pool? Transplantation 2005;80(suppl 1):S138-S141.
3. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997; 276:60-66.
4. Petersen BE, Grossbard B, Hatch H, Pi L, Deng J, Scott EW. Mouse A6-positive hepatic oval cells also express several hematopoietic stem cell markers. HEPATOLOGY 2003;37:632-640.
5. Sanchez A, Factor VM, Schroeder IS, Nagy P, Thorgeirsson SS. Activation of NF-kappaB and STAT3 in rat oval cells during 2-acetylaminofluorene/ partial hepatectomy-induced liver regeneration. HEPATOLOGY 2004;39: 376-385.
6. Wang X, Foster M, Al Dhalimy M, Lagasse E, Finegold M, Grompe M. The origin and liver repopulating capacity of murine oval cells. Proc Natl Acad Sci U S A 2003;100(suppl 1):11881-11888.
7. Fujio K, Hu Z, Evarts RP, Marsden ER, Niu CH, Thorgeirsson SS. Co-expression of stem cell factor and c-kit in embryonic and adult liver. Exp Cell Res 1996;224:243-250.
8. Theise ND, Badve S, Saxena R, Henegariu O, Sell S, Crawford JM, et al. Derivation of hepatocytes from bone marrow cells in mice after radiation-induced myeloablation. HEPATOLOGY 2000;31:235-240.
9. Paku S, Nagy P, Kopper L, Thorgeirsson SS. 2-Acetylaminofluorene dose-dependent differentiation of rat oval cells into hepatocytes: confocal and electron microscopic studies. HEPATOLOGY 2004;39:1353-1361.
10. Encke J, Kraus T, Mehrabi A, Stremmel W, Sauer P. Treatment of hepatitis C virus reinfection after liver transplantation. Transplantation 2005; 80(suppl 1):S125-S127.
11. Harada H, Pavlick KP, Hines IN, Lefer DJ, Hoffman JM, Bharwani S, et al. Sexual dimorphism in reduced-size liver ischemia and reperfusion injury in mice: role of endothelial cell nitric oxide synthase. Proc Natl Acad Sci U S A 2003;100:739-744.
12. Harada H, Hines IN, Flores S, Gao B, McCord J, Scheerens H, et al. Role of NADPH oxidase-derived superoxide in reduced size liver ischemia and reperfusion injury. Arch Biochem Biophys 2004;423:103-108.
13. Sun R, Gao B. Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-gamma). Gastroenterology 2004;127: 1525-1539.
14. Ito H, Ando K, Nakayama T, Taniguchi M, Ezaki T, Saito K, et al. Role of Valpha 14 NKT cells in the development of impaired liver regeneration in vivo. HEPATOLOGY 2003;38:1116-1124.
15. Matsushita T, Ando K, Kimura K, Ohnishi H, Imawari M, Muto Y, et al. IL-12 induces specific cytotoxicity against regenerating hepatocytes in vivo. Int Immunol 1999;11:657-665.
16. Sakamoto T, Ezure T, Lunz J, Murase N, Tsuji H, Fung JJ, et al. Concanavalin A simultaneously primes liver hematopoietic and epithelial progenitor cells for parallel expansion during liver regeneration after partial hepatectomy in mice. HEPATOLOGY 2000;32:256-267.
17. Habu S, Fukui H, Shimamura K, Kasai M, Nagai Y, Okumura K, et al. In vivo effects of anti-asialo GM1.1. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. J Immunol 1981;127:34-38.
18. Wheeler MD, Smutney OM, Check JF, Rusyn I, Schulte-Hermann R, Thurman RG. Impaired Ras membrane association and activation in PPARalpha knockout mice after partial hepatectomy. Am J Physiol Gastrointest Liver Physiol 2003;284:G302-G312.
19. Isayama F, Froh M, Yin M, Conzelmann LO, Milton RJ, McKim SE, et al. TNF alpha-induced Ras activation due to ethanol promotes hepatocyte proliferation independently of liver injury in the mouse. HEPATOLOGY 2004;39:721-731.
20. Kusters S, Gantner F, Kunsde G, Tiegs G. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 1996;111:462-471.
21. Bisgaard HC, Muller S, Nagy P, Rasmussen LJ, Thorgeirsson SS. Modulation of the gene network connected to interferon-gamma in liver regeneration from oval cells. Am J Pathol 1999;155:1075-1085.
22. Oe S, Lemmer ER, Conner EA, Factor VM, Leveen P, Larsson J, et al. Intact signaling by transforming growth factor beta is not required for termination of liver regeneration in mice. HEPATOLOGY 2004;40:1098-1105.
23. Romero-Gallo J, Sozmen EG, Chytil A, Russell WE, Whitehead R, Parks WT, et al. Inactivation of TGF-beta signaling in hepatocytes results in an increased proliferative response after partial hepatectomy. Oncogene 2005; 24:3028-3041.
24. Lowes KN, Croager EJ, Olynyk JK, Abraham LJ, Yeoh GC. Oval cell-mediated liver regeneration: Role of cytokines and growth factors. J Gastroenterol Hepatol 2003;18:4-12.
25. Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N, et al. Bone marrow as a potential source of hepatic oval cells. Science 1999;284:1168-1170.
26. Petersen BE, Goff JP, Greenberger JS, Michalopoulos GK. Hepatic oval cells express the hematopoietic stem cell marker Thy-1 in the rat. HEPATOLOGY 1998;27:433-445.
27. Grompe M. The role of bone marrow stem cells in liver regeneration. Semin Liver Dis 2003;23:363-372.
28. Lu M, Kawamoto H, Katsube Y, Ikawa T, Katsura Y. The common myelolymphoid progenitor: a key intermediate stage in hemopoiesis generating T and B cells. J Immunol 2002;169:3519-3525.
29. Ito CY, Li CY, Bernstein A, Dick JE, Stanford WL. Hematopoietic stem cell and progenitor defects in Sca-1/Ly-6A-null mice. Blood 2003;101: 517-523.
30. Hines IN, Wheeler MD. Recent advances in alcoholic liver disease. III. Role of the innate immune response in alcoholic hepatitis. Am J Physiol Gastrointest Liver Physiol 2004;287:G310-G314.
31. Yoshino H, Ueda T, Kawahata M, Kobayashi K, Ebihara Y, Manabe A, et al. Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice. Bone Marrow Transplant 2000;26:1211-1216.
32. Miyagi T, Takehara T, Tatsumi T, Suzuki T, Jinushi M, Kanazawa Y, et al. Concanavalin a injection activates intrahepatic innate immune cells to provoke an antitumor effect in murine liver. HEPATOLOGY 2004;40:1190-1196.
33. Yamada Y, Webber EM, Kirillova I, Peschon JJ, Fausto N. Analysis of liver regeneration in mice lacking type 1 or type 2 tumor necrosis factor receptor: requirement for type 1 but not type 2 receptor. HEPATOLOGY 1998; 28:959-970.
34. Yamada Y, Kirillova I, Peschon JJ, Fausto N. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc Natl Acad Sci U S A 1997;94:1441-1446.
35. Cressman DE, Greenbaum LE, DeAngelis RA, Ciliberto G, Furth EE, Poli V, et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996;274:1379-1383.
36. Sakamoto T, Liu Z, Murase N, Ezure T, Yokomuro S, Poli V, et al. Mitosis and apoptosis in the liver of interleukin-6-deficient mice after partial hepatectomy. HEPATOLOGY 1999;29:403-411.
37. Wuestefeld T, Klein C, Streetz KL, Betz U, Lauber J, Buer J, et al. Interleukin-6/glycoprotein 130-dependent pathways are protective during liver regeneration. J Biol Chem 2003;278:11281-11288.
38. Brooling JT, Campbell JS, Mitchell C, Yeoh GC, Fausto N. Differential regulation of rodent hepatocyte and oval cell proliferation by interferon gamma. HEPATOLOGY 2005;41:906-915.
39. Taylor A, Verhagen J, Blaser K, Akdis M, Akdis CA. Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells. Immunology 2006;117:433-442.
40. Chen W, Frank ME, Jin W, Wahl SM. TGF-beta released by apoptotic T cells contributes to an immunosuppressive milieu. Immunity 2001;14:715-725.
41. Hamad AR, Schneck JP. Antigen-induced T cell death is regulated by CD4 expression. Int Rev Immunol 2001;20:535-546.
42. Jaruga B, Hong F, Sun R, Radaeva S, Gao B. Crucial role of IL-4/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes. J Immunol 2003;171:3233-3244.
43. Crosby HA, Kelly DA, Strain AJ. Human hepatic stem-like cells isolated using c-kit or CD34 can differentiate into biliary epithelium. Gastroenterology 2001;120:534-544.
44. Takamiya M, Okigaki M, Jin D, Takai S, Nozawa Y, Adachi Y, et al. Granulocyte colony-stimulating factor-mobilized circulating c-Kit+/Flk-1+ progenitor cells regenerate endothelium and inhibit neointimal hyperplasia after vascular injury. Arterioscler Thromb Vasc Biol 2006;26:751-757.
45. Kubora H, Reid LM. Clonogenic hepatoblasts, common precursors for hepatocytic and biliary lineages, are lacking classical major histocompatibility complex class I antigen. Proc Natl Acad Sci U S A 2000;97:12132-12137.
46. Douagi I, Vieira P, Cumano A. Lymphocyte commitment during embryonic development, in the mouse. Semin Immunol 2002;14:361-369.
47. Crowe NY, Coquet JM, Berzins SP, Kyparissoudis K, Keating R, Pellicci DG, et al. Differential antitumor immunity mediated by NKT cell subsets in vivo. J Exp Med 2005;202:1279-1288.
48. Margalit M, Shibolet O, Klein A, Elinav E, Alper R, Thalenfeld B, et al. Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes. Int J Cancer 2005;115:443-449.
49. Itoh H, Abo T, Sugawara S, Kanno A, Kumagai K. Age-related variation in the proportion and activity of murine liver natural killer cells and their cytotoxicity against regenerating hepatocytes. J Immunol 1988;141:315-323.
50. Exley MA, Koziel MJ. To be or not to be NKT: natural killer T cells in the liver. HEPATOLOGY 2004;40:1033-1040.